Global Metal Stents Market Size By Type (Nitinol Stents, Stainless Steel Stents), By Application (Hospitals, Ambulatory Surgery Centers), By Region, And Segment Forecasts, 2023 to 2032

The Global Metal Stents Market was valued at USD 11.1 billion in 2023 and is projected to reach USD 18.4 billion by 2031, growing at a CAGR of 6.7% during the forecast period of 2023–2031. Metal stents are widely used in treating various cardiovascular, urological, and gastrointestinal conditions due to their superior structural integrity and long-term patency. The rising incidence of cardiovascular diseases, advancements in stent design, and the increasing adoption of minimally invasive procedures are key factors propelling market growth. Furthermore, the growing aging population and the corresponding rise in chronic diseases contribute significantly to market expansion.

Drivers:

1. Rising Prevalence of Cardiovascular and Chronic Diseases

The surge in lifestyle-related disorders such as coronary artery disease and peripheral artery disease globally has created a high demand for metal stents. Their proven efficacy in restoring vessel patency and reducing restenosis rates makes them a preferred option in interventional procedures.

2. Technological Advancements in Stent Design

Continuous innovations, including the development of drug-eluting stents (DES), bioresorbable metallic stents (BMS), and coated metal stents, have enhanced patient outcomes. These advancements offer better biocompatibility, reduce the risk of thrombosis, and improve long-term vascular healing.

3. Minimally Invasive Procedures Gaining Popularity

Minimally invasive techniques like percutaneous coronary intervention (PCI) have become mainstream in modern medical practice, offering quicker recovery and fewer complications. This trend significantly boosts the adoption of metal stents.

Restraints:

1. Risk of In-Stent Restenosis and Thrombosis

Despite improvements, certain stents still pose risks like restenosis or late stent thrombosis. These clinical challenges may limit their usage and push demand for alternative therapies.

2. High Cost of Advanced Stents

The price of technologically advanced metal stents remains high, particularly in developing economies, creating accessibility issues for patients without health insurance or reimbursement support.

Opportunity:

1. Emerging Markets Expansion

Asia-Pacific, Latin America, and the Middle East are witnessing rapid improvements in healthcare infrastructure. The increasing number of catheterization labs and rising awareness of cardiovascular treatments in these regions provide lucrative growth opportunities.

2. Rising Demand for Bioresorbable and Coated Metal Stents

Next-generation metal stents with bioresorbable and polymer-coated properties are gaining traction for their ability to offer temporary scaffolding and improved healing, opening new commercial avenues.

Market by System Type Insights:

Based on system type, Drug-Eluting Stents (DES) accounted for the largest market share in 2023. These stents are embedded with antiproliferative drugs that minimize the risk of restenosis, leading to high demand globally. Bare-Metal Stents (BMS), while declining in use, still hold significance in specific patient populations and are witnessing stable adoption in resource-limited settings.

Market by End-use Insights:

Hospitals emerged as the dominant end-user segment in 2023, attributed to the availability of skilled personnel, advanced imaging facilities, and comprehensive cardiac care units. Ambulatory Surgical Centers (ASCs) are anticipated to witness the fastest growth, driven by the shift toward outpatient procedures, cost-efficiency, and shorter patient recovery times.

Market by Regional Insights:

North America held the largest market share in 2023 due to high cardiovascular disease prevalence, robust healthcare infrastructure, and favorable reimbursement scenarios. Asia-Pacific is projected to grow at the fastest rate during the forecast period, driven by healthcare modernization, increased medical tourism, and rising awareness of interventional cardiology.

Competitive Scenario:

Key players in the Global Metal Stents Market include Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, B. Braun Melsungen AG, Cook Medical, Terumo Corporation, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cordis (a Cardinal Health company), and Stryker Corporation. These companies are focusing on product innovation, strategic acquisitions, and global expansion. Noteworthy developments include:

2023: Boston Scientific launched its next-generation drug-eluting stent with biodegradable polymer coating for enhanced vascular healing.

2024: Abbott received FDA approval for a new metallic stent targeting peripheral artery disease with improved deliverability and lower restenosis rates.

2025: Medtronic expanded its cardiovascular product line by acquiring a startup specializing in bioresorbable metal stent technologies.

Scope of Work – Global Metal Stents Market

Report Metric Details

Market Size (2023) USD 11.1 billion

Projected Market Size (2031) USD 18.4 billion

CAGR (2023–2031) 6.7%

Market Segments By System Type, End-use, Region

Growth Drivers Rising cardiovascular diseases, technology innovation, shift toward minimally invasive surgeries

Opportunities Emerging markets, adoption of bioresorbable and coated metal stents

Key Market Developments:

Boston Scientific introduced a new DES with enhanced polymer degradation features in early 2023.

Medtronic entered into a partnership with a leading Asian healthcare provider to expand stent distribution in Southeast Asia.

Abbott launched a first-in-class peripheral stent targeting small-diameter vessels in 2024.

FAQs:

1) What is the current market size of the Global Metal Stents Market?

The Global Metal Stents Market was valued at USD 11.1 billion in 2023.

2) What is the major growth driver of the Global Metal Stents Market?

The primary growth driver is the increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive interventions.

3) Which is the largest region during the forecast period in the Global Metal Stents Market?

North America leads the market due to advanced healthcare infrastructure and high disease incidence.

4) Which segment accounted for the largest market share in the Global Metal Stents Market?

Drug-Eluting Stents (DES) accounted for the largest share based on system type in 2023.

5) Who are the key market players in the Global Metal Stents Market?

Key players include Boston Scientific, Medtronic, Abbott, Terumo, and Cook Medical.